The observer effect—the idea that observing a phenomenon changes it—is often seen as a problem to control, but this paper argues it should be actively studied and used. Mindfulness practices, which cultivate present-moment, nonjudgmental awareness, are proposed as a way to account for and intentionally harness this effect. In research, mindfulness training may help participants give more precise self-reports by reducing reactive biases. Evidence suggests mindfulness improves interoceptive awareness and reduces automatic judgment, potentially increasing measurement validity. Clinically, therapies often aim to make unconscious patterns observable; mindfulness cultivates meta-awareness, allowing individuals to observe cravings or anxiety without reactivity, facilitating psychological change. The paper proposes developing an observer-effect index to code observer influence.
Repeated low doses of psilocybin were safe and well tolerated in adults with major depressive disorder but did not show greater antidepressant effects than placebo. In a randomized, double-blind trial, 39 participants received either 2 mg psilocybin or placebo weekly for four weeks. Both groups reported similar reductions in depression scores on the PHQ-9 (psilocybin: -5.4; placebo: -6.0) and other measures. The microdose-first group showed slightly more improvement on a dysfunctional attitudes scale than the placebo-first group. No serious adverse events occurred, and symptom reductions continued during an open-label phase. Trial participation itself contributed to clinically meaningful improvement.